Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Liquidia Corporation(LQDA) | 9,243,627 | 10,360,945 | +1,117,318 | $58.60M | $124.64M | 42.03% | +$66.04M |
| Alimera Sciences Inc | 16,835,154 | 16,835,154 | 0 | $52.19M | $72.73M | 24.53% | +$20.54M |
| Anika Therapeutics Inc | 1,081,360 | 1,081,360 | 0 | $20.15M | $24.50M | 8.26% | +$4.36M |
| Exelixis, Inc.(EXEL) | 910,730 | 910,730 | 0 | $19.90M | $21.85M | 7.37% | +$1.95M |
| Standard BioTools Inc.(LAB) | 7,622,413 | 7,042,413 | -580,000 | $22.10M | $15.56M | 5.25% | -$6.54M |
| Evolus, Inc.(EOLS) | 1,683,836 | 1,317,856 | -365,980 | $15.39M | $13.88M | 4.68% | -$1.51M |
| Agios Pharmaceuticals, Inc.(AGIO) | 4,833 | 441,833 | +437,000 | $119.6K | $9.84M | 3.32% | +$9.72M |
| Y-Mabs Therapeutics Inc | 23,321 | 1,048,425 | +1,025,104 | $127.1K | $7.15M | 2.41% | +$7.02M |
| Verona Pharma PlcADS | 183,064 | 183,064 | 0 | $2.98M | $3.64M | 1.23% | +$655.4K |
| Adma Biologics Inc | 597,513 | 473,087 | -124,426 | $2.14M | $2.14M | 0.72% | -$744 |
| Societal Cdmo Inc | 1,689,768 | 1,689,768 | 0 | $794.2K | $592.3K | 0.20% | -$201.9K |
| VERRICA PHARMACEUTICALS INCCOM(VRCA) | 259,593 | 0 | -259,593 | $1.01M | $0 | — | -$1.01M |